Henry Schein, Inc. (NASDAQ:HSIC – Free Report) – Investment analysts at Zacks Research boosted their Q2 2025 earnings per share (EPS) estimates for Henry Schein in a research report issued to clients and investors on Tuesday, April 16th. Zacks Research analyst U. Biswas now anticipates that the company will post earnings per share of $1.27 for the quarter, up from their prior estimate of $1.26. The consensus estimate for Henry Schein’s current full-year earnings is $5.07 per share.
Henry Schein (NASDAQ:HSIC – Get Free Report) last issued its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The firm had revenue of $3.02 billion during the quarter, compared to analyst estimates of $3 billion. During the same quarter in the previous year, the business posted $1.21 EPS. Henry Schein’s revenue was down 10.5% compared to the same quarter last year.
Read Our Latest Research Report on Henry Schein
Henry Schein Trading Down 0.3 %
NASDAQ:HSIC opened at $69.97 on Thursday. The business’s 50-day moving average is $74.43 and its two-hundred day moving average is $72.48. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00. Henry Schein has a 12 month low of $60.01 and a 12 month high of $85.39. The firm has a market capitalization of $8.99 billion, a PE ratio of 22.21, a price-to-earnings-growth ratio of 1.76 and a beta of 0.87.
Insider Activity at Henry Schein
In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the transaction, the insider now directly owns 209,562 shares in the company, valued at $15,585,125.94. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares in the company, valued at $5,430,462.24. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Henry Schein
Several hedge funds and other institutional investors have recently made changes to their positions in the business. Baystate Wealth Management LLC raised its holdings in Henry Schein by 2,500.0% during the third quarter. Baystate Wealth Management LLC now owns 520 shares of the company’s stock worth $39,000 after purchasing an additional 500 shares in the last quarter. McGlone Suttner Wealth Management Inc. bought a new stake in Henry Schein during the fourth quarter worth approximately $39,000. Neo Ivy Capital Management bought a new stake in Henry Schein during the third quarter worth approximately $46,000. Covestor Ltd raised its holdings in Henry Schein by 88.4% during the first quarter. Covestor Ltd now owns 861 shares of the company’s stock worth $75,000 after purchasing an additional 404 shares in the last quarter. Finally, Harbour Investments Inc. raised its holdings in Henry Schein by 27,725.0% during the fourth quarter. Harbour Investments Inc. now owns 1,113 shares of the company’s stock worth $84,000 after purchasing an additional 1,109 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More
- Five stocks we like better than Henry Schein
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Comprehensive PepsiCo Stock Analysis
- Investing In Automotive Stocks
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Election Stocks: How Elections Affect the Stock Market
- Bear Market Funds to Watch This Year
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.